Although it is known that cotransport of Na ϩ , K ϩ , and Cl Ϫ is the first step in tubuloglomerular feedback (TGF), subsequent steps are unclear. We hypothesized that Na ϩ -K ϩ -2Cl Ϫ entry via the luminal Na ϩ -K ϩ -2Cl Ϫ cotransporter elevates intracellular Cl Ϫ , increases electrogenic Cl Ϫ efflux across the basolateral membrane, and depolarizes the macula densa, initiating TGF. We perfused afferent arterioles with macula densa attached. The macula densa was perfused with solutions containing either 5 mM Na ϩ and 3 mM Cl Ϫ (low NaCl) or 80 mM Na ϩ and 77 mM Cl Ϫ (high NaCl). When the macula densa perfusate was changed from low to high NaCl, afferent arteriole diameter decreased from 15.8 Ϯ 0.8 to 13.1 Ϯ 0.7 mm (P Ͻ 0.05). Adding 10 M furosemide to the macula densa lumen blocked TGF. When nystatin, a group I cation ionophore, was added to the macula densa lumen together with furosemide in the presence of low NaCl, it induced TGF (from 18.0 Ϯ 1.5 to 15.6 Ϯ 1.6 mm; P ϭ 0.003). When valinomycin, a K ϩ -selective ionophore, was added to the macula densa lumen together with furosemide in the presence of low NaCl containing 5 mM K ϩ , it did not induce TGF. Subsequent addition of 50 mM KCl to the macula densa perfusate induced TGF (from 21.7 Ϯ 0.8 to 17.5 Ϯ 1.3 mm; P ϭ 0.0047; n ϭ 6). Adding 50 mM KCl without valinomycin did not induce TGF. When 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB; 1 M), a Cl Ϫ channel blocker, was added to the bath, it blocked TGF induced by high NaCl, but did not block TGF induced by valinomycin plus 50 mM KCl. NPPB did not alter afferent arteriole constriction induced by norepinephrine. We concluded that increased NaCl in the lumen of the macula densa leads to influx of Cl Ϫ via the Na ϩ -K ϩ -2Cl Ϫ cotransporter. The accelerated transport increases intracellular Cl Ϫ . The subsequent exit of Cl Ϫ across the basolateral membrane via Cl Ϫ channels in turn leads to depolarization of the macula densa and thereby induces TGF. afferent arteriole; transport; chloride channel TUBULOGLOMERULAR FEEDBACK (TGF) is generally thought to be mediated by the macula densa, which detects changes in NaCl concentration ([NaCl] ) in the distal tubule and transmits a feedback signal to the glomerular vessels (5, 24) . TGF is a major component of renal autoregulation, maintaining homeostasis by regulating renal blood flow and glomerular filtration of a single nephron (23, 33) . Many investigators have attempted to define the various steps in TGF signal transmission and characterize the factors that modulate this process. Numerous in vivo single-nephron micropuncture studies have established that increased [NaCl] and/or osmolality of the tubular fluid at the macula densa decreases the single-nephron glomerular filtration rate. In vivo micropuncture (15, 33) and in vitro studies (2) showed that furosemide and other loop diuretics that inhibit NaCl cotransport effectively block TGF responses. Electrophysiological studies have shown that macula densa basolateral membrane potential (V bl ) is depolarized in response to increased luminal fluid [NaCl] (1). Addition of furosemide induced hyperpolarization or blocked depolarization of V bl in response to an increase in luminal [NaCl] (11), thereby indicating that NaCl transport by the cotransporter is necessary for the change in voltage (21) . Both the TGF response and the V bl depolarization occurred over the same range of luminal [NaCl] . Although an active Na 
METHODS
Rabbit afferent arterioles with the macula densa attached were isolated and perfused according to the method routinely used in our laboratory (8) (9) (10) . Briefly, the left kidney was removed and sliced along the corticomedullary axis, and the slices were placed in ice-cold minimum essential medium (MEM) containing 5% BSA. Superficial afferent arterioles with glomeruli intact were microdissected together with adherent tubular segments consisting of portions of the thick ascending limb of the loop of Henle, macula densa, and early distal tubule. The microdissected complex was transferred (with a micropipette) to a temperature-regulated chamber mounted on an inverted microscope with Hoffmann modulation. Both the afferent arteriole and the end of either the distal tubule or the thick ascending limb were cannulated with an array of glass pipettes. Intraluminal pressure was measured by the Landis technique via a fine pipette introduced into the arteriole through the perfusion pipette. The afferent arteriole was perfused with oxygenated MEM supplemented with 5% BSA and (in mM) 5 NaHCO 3, 10 NaCl, 10 HEPES, and 10 NaOH. Intraluminal pressure was maintained at 60 mmHg throughout the experiment. The macula densa was perfused with physiological saline consisting of (in mM) 10 HEPES, 3 KCl, 1.2 MgSO 4, 2.0 KPO4, 5 NaHCO3, 5.5 glucose, 1.0 calcium lactate 2, and either 74 NaCl (high [NaCl]) or 0 NaCl (low [NaCl] ). MEM and physiological saline were oxygenated with 100% O2, and the pH of each solution was 7.4. The bath was similar to the arteriolar perfusate except that it contained 0.1% BSA. Images of the afferent arteriole were displayed at magnifications up to ϫ1,980 and recorded with a video system consisting of a camera, monitor, and video recorder. Diameter was measured using an imageanalysis system (Universal Imaging, West Chester, PA) within 10 min after switching luminal or basolateral solutions.
Nystatin, a group I cation ionophore, and valinomycin, a K ϩ -selective ionophore, were purchased from Sigma Chemical (St. Louis, MO), and 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB), a Cl Ϫ channel blocker, was a generous gift from Hoechst Marion Roussel Chemical Research (Frankfurt, Germany).
Statistics. Each separate experiment was approached in an analogous manner. The designs were repeated measures with the same afferent arteriole being measured under different conditions. In all cases, a subset of all possible contrasts was specified in advance as being of primary importance. To analyze a specific difference, a paired t-test was used. All tests were two sided, and results are presented as means Ϯ SE. For each experiment, comparisons of interest were considered to be a set, and Holm's multiple-comparisons procedure was used to adjust for multiple testing (26) . A value of P Ͻ 0.05 was considered significant.
RESULTS
We first demonstrated that furosemide blocks the TGF response induced by high [NaCl] in our preparation as it does in in vivo micropuncture experiments. When the macula densa perfusate was changed from low to high [NaCl] , afferent arteriole diameter decreased from 17.7 Ϯ 0.9 to 15.0 Ϯ 1.5 m (P Ͻ 0.01) within 10 min (Fig. 1A) . When the luminal solution was changed back to low [NaCl], diameter measurements returned to baseline values. After 10 M furosemide was added to the lumen of the macula densa, afferent arteriole diameter increased slightly from 17.6 Ϯ 1.0 to 18.2 Ϯ 0.6 m. When the luminal perfusate was changed from low to high [NaCl] in the presence of furosemide, diameter did not change significantly (from 18.2 Ϯ 0.6 to 18.0 Ϯ 1.0 m; n ϭ 5). In time controls, afferent arteriole diameter decreased from 15.8 Ϯ 0.8 to 13.1 Ϯ 0.7 m (P Ͻ 0.05; Fig. 1B ) when the solution perfusing the macula densa was first changed from low to high [NaCl]. When we repeated the process, diameter decreased from 15.6 Ϯ 0.6 to 13.1 Ϯ 1.1 m (P Ͻ 0.02; n ϭ 5). Taken together, these data show that furosemide blocks TGF in our preparation.
Because it is not clear whether entry of Na
, or some combination of these ions is required for TGF, we first examined the effect of nystatin, a group I cation ionophore, on TGF. Owing to the differing electrochemical gradients of Na ϩ and K ϩ , nystatin primarily allows Na ϩ entry. When the solution perfusing the macula densa was changed from low to high [NaCl], afferent arteriole diameter decreased from 17.6 Ϯ 1.6 to 15.2 Ϯ 1.8 m (P Ͻ 0.001). Diameter then increased to 18.0 Ϯ 1.5 m when the lumen was perfused with low [NaCl] and furosemide. When nystatin (100 M) was added to the macula densa lumen in the presence of low [NaCl] and furosemide, the diameter decreased from 18.0 Ϯ 1.5 to 15.6 Ϯ 1.6 m (P Ͻ 0.003; Fig. 2 ) within 10 min. The TGF response induced by nystatin was not significantly different from that induced by high [NaCl] . To verify that constriction of the afferent arteriole was not due to a direct effect of nystatin on the afferent arteriole, we investigated the ability of the ionophore to constrict isolated perfused vessels. Nystatin at 10 Ϫ6 M and 10 Ϫ5 M had no effect on diameter. However, adding 10 Ϫ4 M nystatin to the bath caused a transient decrease in diameter (lasting Ͻ30 s) from 16.8 Ϯ 1.1 to 7.9 Ϯ 2.2 m, which then returned to baseline. To test arteriolar contractility, at the end of the experiment 10 Ϫ6 M norepinephrine was added to the bath. All of the arterioles reacted normally. These data show that nystatin can cause TGF after the Na
Ϫ cotransporter is blocked by furosemide.
Even with low [Na ϩ ] perfusing the macula densa lumen, nystatin initially increased Na ϩ entry into the macula densa due to the negative membrane potential of the cell. To test whether Na ϩ entry per se is the initiating step of TGF, we next examined the effect of valinomycin, a K ϩ -selective ionophore, on TGF. When the solution perfusing the macula densa was changed from low to high [NaCl], afferent arteriole diameter decreased from 21.1 Ϯ 0.8 to 17.8 Ϯ 1.0 m (P ϭ 0.003). Diameter then increased to 21.6 Ϯ 0.8 m when we changed to low [NaCl] plus furosemide. Adding 1 M valinomycin to the macula densa lumen in the presence of low [NaCl] and furosemide did not change diameter significantly. However, when the KCl concentration ([KCl]) of this solution was increased by 50 mM, afferent arteriole diameter decreased from 21.7 Ϯ 0.8 to 17.5 Ϯ 1.3 m (P ϭ 0.0047; n ϭ 6; Fig. 3A) .
To show that the TGF response is not due to the change in [Cl Ϫ ] and cannot be elicited by high [K ϩ ] alone, we reversed the order of the addition of KCl and valinomycin (Fig. 3B) . With low [NaCl] and furosemide perfusing the macula densa, increasing [KCl] by 50 mM did not affect afferent arteriole diameter in the absence of valinomycin. However, when valinomycin was subsequently added, the afferent arteriole diameter decreased from 19.2 Ϯ 0.34 to 15.7 Ϯ 0.61 m (P ϭ 0.0003; n ϭ 6). These data show that neither 50 mM KCl nor valinomycin alone can induce TGF, but if both are added to the solution perfusing the macula densa, TGF is initiated. Blockade of the basolateral Cl Ϫ channel with NPPB has been shown to prevent the depolarization induced by increasing [NaCl] at the macula densa (20, 21) . To investigate whether blocking the basolateral Cl Ϫ channel blunts TGF, we examined the effect of NPPB on TGF. We first investigated whether NPPB is able to block TGF induced by high [NaCl] . When the solution perfusing the macula densa was changed from low to high [NaCl] 
Because NPPB blocked TGF in response to changing [NaCl] at the macula densa, we next investigated whether NPPB could block arteriolar constriction induced by depolarization. In the presence of low [NaCl], afferent arteriole diameter was 20.4 Ϯ 1.4 m. When the macula densa perfusate was changed to high [NaCl] , diameter decreased to 17.1 Ϯ 1.31 m. When 50 mM KCl was added to the macula densa perfusate in the presence of NPPB and valinomycin, afferent arteriole diameter decreased from 20.7 Ϯ 1.2 to 16.8 Ϯ 1.5 m (P ϭ 0.002; n ϭ 6; Fig. 5 ). These data suggest that NPPB cannot block TGF induced by valinomycin plus 50 mM KCl.
To rule out the possibility that the effect of NPPB on TGF is due to direct alteration of afferent arteriole contractility by NPPB, we examined the effect of norepinephrine on the afferent arteriole with and without NPPB. Norepinephrine constricted afferent arterioles in a dose-dependent manner. In the presence of NPPB, norepinephrine caused afferent arteriole constriction that was identical to control: diameter decreased to 73% and 29% of baseline at 10 Ϫ7 M and 5 ϫ 10 Ϫ7 M norepinephrine, respectively. Thus we eliminated the possibility that NPPB inhibits TGF due to reduced afferent arteriole contractility. Taken together, our results demonstrate that Cl Ϫ efflux is important for initiation of the TGF response.
DISCUSSION
The nature of the luminal activator of TGF remains unclear. Early studies provided evidence that osmolality, Na ϩ , Cl Ϫ , and NaCl are critical for initiation of TGF (14) . Accumulated data indicate that an active Na ϩ -K ϩ -2Cl Ϫ cotransporter in the luminal membrane of the macula densa is necessary for TGF (21, 23) of the macula densa perfusate was changed from low to high [NaCl] in the presence of NPPB (n ϭ 6; *P Ͻ 0.01, low vs. high [NaCl]). caused by nystatin increases intracellular [Na ϩ ] (27, 32) . The fact that nystatin causes Na ϩ entry into the macula densa even in the presence of 5 mM Na ϩ (as in our experiments) is based on the reported resting membrane potential of the macula densa. In the absence of nystatin, the macula densa membrane potential is approximately Ϫ61 mV. When nystatin was added to the macula densa perfusate, the Na ϩ and K ϩ permeabilities of the luminal membrane dramatically increased. Although in theory nystatin is nonselective, Na ϩ permeates nystatin-induced channels to a greater extent than K ϩ , because K ϩ is near its equilibrium potential and Na ϩ is not. Our data show that nystatin induces TGF in the presence of low [NaCl] and furosemide concentration. The vasoconstriction induced by perfusing the macula densa with nystatin cannot be due to nystatin exiting the lumen of the tubule and affecting either the basolateral membrane of the macula densa or the afferent arteriole directly. Once nystatin is incorporated into the luminal membrane, it does not diffuse past the tight junctions to the basolateral membrane, and owing to its lipophilicity it does not easily leave the membrane once it has entered. Additionally, the flow rate of the macula densa perfusate was ϳ100 nl/min, whereas the bath flow rate was 10 6 times greater (1 ml/min). Finally, when we added nystatin to the bath at 10 Ϫ6 M and 10 Ϫ5 M, it had no effect on afferent arteriole diameter. However, adding 10 Ϫ4 M nystatin did cause a transient decrease in diameter (lasting Ͻ30 s) in isolated afferent arterioles, which then returned to baseline. Given that 1) the time course was different from the nystatin-induced TGF response, 2) only 10
Ϫ4
M nystatin induced constriction, and 3) we used 10
M nystatin in the macula densa to induce TGF and thus the concentration reaching the afferent arterioles must have been lower, it appears improbable that nystatin-induced TGF was due to a direct effect on the afferent arterioles.
The discrepancy between nystatin-induced TGF and the direct effect of nystatin on afferent arterioles is likely due to the concentration of nystatin that we used. Different cells require different concentrations of nystatin to change the intracellular [Na ϩ ]. Additionally, nystatin would be expected to bind albumin, which would decrease the effective concentration. Because we had albumin in the bath, the effective concentration of nystatin was likely lower than the calculated concentration.
To investigate whether Na ϩ entry into the macula densa per se initiates TGF, valinomycin (a K ϩ -selective ionophore) and high [K ϩ ] in the macula densa lumen were used to enhance K ϩ entry. This technique is commonly employed to depolarize vascular smooth muscle cells as well as other cell types (25) . After the Na ϩ -K ϩ -2Cl Ϫ cotransporter was blocked by furosemide, addition of 50 mM KCl to the low-[NaCl] macula densa perfusate in the presence of valinomycin induced TGF. These data indicate that Na ϩ entry per se was not likely the initiator of TGF.
After consideration of the valinomycin data, we asked what effects nystatin has on cells in addition to increasing Na ϩ entry. The dramatic increase in Na ϩ permeability caused by nystatin has been shown to depolarize the membrane potential (27, 32) . The fact that nystatin depolarizes the macula densa even in the presence of 5 mM Na ϩ (as in our experiments) can be shown using the Goldman-Hodgkin-Katz equation and the reported resting membrane potential of the macula densa. In the absence of nystatin, the macula densa membrane potential is approximately Ϫ61 mV. When nystatin is added to the macula densa perfusate, the Na ϩ and K ϩ permeabilities of the luminal membrane dramatically increase. Because nystatin increases the luminal Na ϩ and K ϩ permeabilities to values much larger than those of Cl Ϫ or basolateral K ϩ , these can be ignored when calculating the membrane potential (E). Although in theory nystatin is nonselective, as noted earlier, Na ϩ permeated nystatin-induced channels to a greater extent than K ϩ , because K ϩ was near its equilibrium potential and Na ϩ was not. Thus the equation becomes E ϭ 61 log (K i ϩ 2.9 Na i )/(K 0 ϩ Na 0 )
With this equation, the calculated voltage is Ϫ26 mV, which is a depolarization of 35 mV. That nystatin causes depolarization can be qualitatively predicted by the facts that nystatin dramatically increased the normally low Na ϩ permeability and Na ϩ was far from its equilibrium potential in a direction that favored Na ϩ entry. However, this calculation represents an ideal case in assuming that none of the gradients change. This is not the case in actual fact. In reality, Na ϩ and Cl Ϫ will enter and K ϩ will exit the cell. Consequently, both the electrical and chemical driving forces for Na When the nystatin and valinomycin data are taken together, it appears that TGF is induced by depolarization of the macula densa rather than changes in intracellular [Na
However, it must be noted that these maneuvers have other effects in addition to causing depolarization. Given that we have not actually measured membrane potential, some degree of caution is warranted. For instance, we cannot exclude the role of K ϩ in TGF signal transmission. Given that the macula densa has a luminal K ϩ conductance (7) ] depolarized the membrane potential by Ͼ20 mV in whole-cell patchclamp experiments on the macula densa and also in isolated perfused thick ascending limb-glomerulus preparations (12, 20) . There is a potential explanation for the apparently disparate results. In our experiments, only the luminal membrane was exposed to elevated [K ϩ ]. In the experiments of Schlatter et al. (20, 21) , either both the luminal and basolateral membrane or the basolateral membrane alone was exposed to high [K ϩ ]. Given that the macula densa has a luminal K ϩ conductance, a basolateral K ϩ conductance, and a basolateral Cl Ϫ conductance, depolarization of the luminal membrane would be buffered by the basolateral conductances; thus the depolarization induced by luminal high [K ϩ ] alone may not have been sufficient to initiate TGF.
Changes in macula densa membrane potential as a mediator of TGF were first suggested by Schlatter et al. (21) . Since that report, several authors have confirmed that a change in [NaCl] in the macula densa perfusate alters membrane potential (1, 2, 11, 15) . However, in all of these reports, only macula densa membrane potential was measured. None of the authors measured changes in afferent arteriole diameter in response to depolarization of the macula densa. Thus we believe our data are the first to show that depolarization of the macula densa is sufficient and necessary to cause TGF.
As additional evidence that depolarization of the macula densa is required for a TGF response, and to begin to study what mediates depolarization when the [NaCl] in the macula densa lumen increases, we investigated the role of Cl Ϫ channels. A central mechanism in macula densa-induced TGF is the apical Na
Ϫ cotransporter. This transporter is electroneutral, and therefore changes in its activity will not alter membrane potential. However, activation of this transporter would increase the intracellular concentrations of all three ions. The mechanisms responsible for efflux of Na ϩ and K ϩ either are electroneutral or favor hyperpolarization of the membrane potential. In contrast, Cl Ϫ efflux occurs via basolateral channels (19) and therefore depolarizes the macula densa (16, 21) . Thus we questioned whether Cl Ϫ efflux via the basolateral Cl Ϫ channels is necessary to induce TGF by increasing [NaCl] in the lumen of the macula densa. We examined the effect of NPPB on TGF. Early studies (17) showed that NPPB inhibited half-maximal Cl Ϫ conductance in the thick ascending limb of Henle's loop at a concentration of 8 ϫ 10 Ϫ8 M. However, the blocking effect of NPPB varied considerably from tissue to tissue. In isolated thick ascending limb-glomerulus preparations, adding 10 M NPPB to the bath hyperpolarized macula densa basolateral membrane potential from Ϫ66 Ϯ 7 mV to Ϫ75 Ϯ 5 mV, and this effect was fully reversible (21) . Therefore we chose 1 M NPPB in our preparation. Our data show that when NPPB was added to the bath, it completely inhibited TGF but did not block the TGF induced by valinomycin plus 50 mM KCl. Given that others have shown that NPPB blocked the depolarization of the macula densa caused by increasing [NaCl] in the lumen of the macula densa (16, 21) , our data indicate that Cl Ϫ efflux via basolateral channels is necessary for TGF and that a TGF response can be elicited even when these channels are blocked if the macula densa is depolarized. However, one must always keep in mind that inhibitors have effects other than those desired; thus the effects of NPPB may not have been due to inhibition of Cl Ϫ channels. Changes in luminal [NaCl] at the macula densa alter membrane voltages. This appears to be one of the first steps in the signal transduction chain of the TGF loop. Although the next step is unclear, both Ca 2ϩ and ATP appear to be involved. Peti-Peterdi and Bell (16) showed that increasing lumen [NaCl] elevated cytosolic Ca 2ϩ concentration through a signaling pathway that included Na ϩ /K ϩ /2Cl Ϫ cotransport, basolateral membrane depolarization via Cl Ϫ channels, and Ca 2ϩ entry through voltage-gated Ca 2ϩ channels. It was therefore reasoned that this large depolarization of membrane voltages in the presence of high [NaCl] at the macula densa could promote Ca 2ϩ entry across the basolateral membrane. Ca 2ϩ plays an important role in intracellular signal transduction by activating transport processes or stimulating the release of a chemical mediator. Previous micropuncture studies (4, 6) showed that a cytosolic Ca 2ϩ system was involved in macula densa cell signaling. In these studies, luminal perfusion of the Ca 2ϩ ionophore A-23187 with Ca 2ϩ in the perfusate enhanced TGF, whereas 8-(N,N-diethylamino)octyl-3,4,5-trimetoxybenzoate (TMB-8), which inhibits intracellular release of Ca 2ϩ , reduced TGF. However, the exact role of Ca 2ϩ in TGF remains undefined. There is also substantial evidence that ATP and adenosine play an important role in TGF responses. Mitchell and Navar (13) demonstrated that infusion of ATP into the peritubular capillaries decreased proximal tubule stop-flow pressure, which indicated that ATP caused preglomerular vasoconstriction. Previously we reported that adenosine added to the interstitium (bath and afferent arteriole perfusate) significantly augmented the afferent arteriole constriction induced by high [NaCl] at the macula densa (18) . Recently, Bell et al. (3) found that macula densa cells released ATP via Cl Ϫ channels in response to increases in bath [NaCl] . Interestingly, the macula densa expresses 5Ј-nucleotidase, which converts AMP to adenosine (29) ; moreover, the terminal segment of the afferent arteriole expresses high quantities of the A 1 adenosine receptor (30) , and adenosine is thought to mediate TGF (31) .
From these data, a unified and testable model of TGF can be generated. First, the [NaCl] 
